(19)
(11) EP 1 183 390 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
03.05.2006 Bulletin 2006/18

(45) Mention of the grant of the patent:
04.01.2006 Bulletin 2006/01

(21) Application number: 00935949.8

(22) Date of filing: 12.05.2000
(51) International Patent Classification (IPC): 
C12Q 1/68(2006.01)
G01N 21/64(2006.01)
G01N 33/53(2006.01)
G01N 33/533(2006.01)
C07H 21/02(2006.01)
C12N 15/00(2006.01)
B01J 13/00(2006.01)
C12Q 1/70(2006.01)
G01N 33/00(2006.01)
G01N 33/531(2006.01)
G01N 33/543(2006.01)
C07H 21/04(2006.01)
B05D 1/18(2006.01)
(86) International application number:
PCT/US2000/013197
(87) International publication number:
WO 2000/070094 (23.11.2000 Gazette 2000/47)

(54)

METHODS FOR PREDICTING PREGNANCY OUTCOME IN A SUBJECT BY hCG ASSAY

METHODEN ZUR VOHERSAGE EINES SCHWANGERSCHAFTSERGEBNISSES BEI EINER TESTPERSON MIT HILFE EINES HCG-TESTS

PROCEDE POUR PREVOIR LA CONCLUSION D'UNE GROSSESSE CHEZ UN SUJET PAR DOSAGE DE LA GONADOTROPHINE CHORIONIQUE HUMAINE (HCG)


(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

(30) Priority: 13.05.1999 US 311428

(43) Date of publication of application:
06.03.2002 Bulletin 2002/10

(73) Proprietor: The Trustees of Columbia University in the City of New York
New York, NY 10027-6699 (US)

(72) Inventors:
  • O'CONNOR, John
    New Rochelle, NY 10850 (US)
  • BIRKEN, Steven
    Dumont, NJ 07628 (US)
  • KOVALEVSKAYA, Galina
    New York, NY 10463 (US)

(74) Representative: Lawrence, John 
Barker Brettell, 138 Hagley Road, Edgbaston
Birmingham B16 9PW
Birmingham B16 9PW (GB)


(56) References cited: : 
WO-A2-99/41584
   
  • KOVALEVSKAYA G ET AL: "EARLY PREGNANCY HUMAN CHORIONIC GONADOTROPIN (HCG) ISOFORMS MEASURED BY AN IMMUNOMETRIC ASSAY FOR CHORIOCARCINOMA-LIKE HCG" JOURNAL OF ENDOCRINOLOGY, BRISTOL, GB, vol. 161, 1999, pages 99-106, XP000939395 ISSN: 0022-0795
  • O'CONNOR J F ET AL: "DIFFERENTIAL URINARY GONADOTROPHIN PROFILES IN EARLY PREGNANCY AND EARLY PREGNANCY LOSS" PRENATAL DIAGNOSIS, CHICHESTER, SUSSEX, GB, vol. 18, no. 12, December 1998 (1998-12), pages 1232-1240, XP001098498 ISSN: 0197-3851
  • COLE LAURENCE A: "hCG, its free subunits and its metabolites. Roles in pregnancy and trophoblastic disease." JOURNAL OF REPRODUCTIVE MEDICINE, vol. 43, no. 1, January 1998 (1998-01), pages 3-10, XP008014363 ISSN: 0024-7758
  • BIRKEN S. ET AL.: 'Development and characterization of antibodies to a nicked and hyperglycosylated form of hCG from a choriocarcinoma patient' ENDOCRINE, vol. 10, no. 2, April 1999, pages 137 - 144, XP002930368
  • KOVALEVSKAYA G. ET AAL.: 'Evaluation of nicked human chorionic gonadotropin content in clinical specimens by a specific immunometric assay' CLINICAL CHEMISTRY, vol. 45, no. 1, January 1999, pages 68 - 77, XP002930369
  • COLE L.A. ET AL.: 'The heterogeneity of human chorionic gonadotropin (hCG). III. The occurrence and biological and immunological activities of nicked hCG' ENDOCRINOLOGY, vol. 129, no. 3, 1991, pages 1559 - 1567, XP002930370
  • BERGER P. ET AL.: 'Variants of human chorionic gonadotropin from pregnant women and tumor patients recognized by monoclonal antibodies' JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, vol. 77, no. 2, 1993, pages 347 - 351, XP002930371
  • ACEVEDO H.F. ET AL.: 'Expression of membrane-associated human chorionic gonadotropin, Its subunits and fragments by cultured human cancer cells' CANCER, vol. 69, no. 7, 01 April 1992, pages 1829 - 1842, XP002930372
  • HOERMANN R. ET AL.: 'Molecular heterogeneity of human chorionic gonadotropin in serum and urine from patients with trophoblastic tumors' CLINICAL INVESTIGATION, vol. 71, 1993, pages 953 - 960, XP002930373
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).